211 related articles for article (PubMed ID: 37094986)
1. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.
Chen S; Lu K; Hou Y; You Z; Shu C; Wei X; Wu T; Shi N; Zhang G; Wu J; Chen S; Zhang L; Li W; Zhang D; Ju S; Chen M; Xu B
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37094986
[TBL] [Abstract][Full Text] [Related]
2. IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages.
Han IH; Song HO; Ryu JS
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008126. PubMed ID: 32196489
[TBL] [Abstract][Full Text] [Related]
3. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer.
Huang Y; Tao T; Liu C; Guan H; Zhang G; Ling Z; Zhang L; Lu K; Chen S; Xu B; Chen M
Int J Oncol; 2017 Feb; 50(2):421-431. PubMed ID: 28101571
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane activates the IL-6/HO-1 pathway to promote macrophage M2 polarization and prostate cancer lung metastasis.
Yu F; Bai T
Int Immunopharmacol; 2022 Dec; 113(Pt A):109380. PubMed ID: 36330914
[TBL] [Abstract][Full Text] [Related]
6. IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway.
Zheng T; Ma G; Tang M; Li Z; Xu R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591689
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.
Chen PC; Cheng HC; Wang J; Wang SW; Tai HC; Lin CW; Tang CH
Oncotarget; 2014 Mar; 5(6):1595-608. PubMed ID: 24721786
[TBL] [Abstract][Full Text] [Related]
8. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
9. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.
Yeh CR; Slavin S; Da J; Hsu I; Luo J; Xiao GQ; Ding J; Chou FJ; Yeh S
Mol Cancer; 2016 Jan; 15():7. PubMed ID: 26790618
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
[TBL] [Abstract][Full Text] [Related]
13. YY1 promotes IL-6 expression in LPS-stimulated BV2 microglial cells by interacting with p65 to promote transcriptional activation of IL-6.
Zhang XC; Liang HF; Luo XD; Wang HJ; Gu AP; Zheng CY; Su QZ; Cai J
Biochem Biophys Res Commun; 2018 Jul; 502(2):269-275. PubMed ID: 29803672
[TBL] [Abstract][Full Text] [Related]
14. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
[No Abstract] [Full Text] [Related]
15. CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3.
Zhao C; Zeng N; Zhou X; Tan Y; Wang Y; Zhang J; Wu Y; Zhang Q
BMC Cancer; 2023 May; 23(1):392. PubMed ID: 37127625
[TBL] [Abstract][Full Text] [Related]
16. Dauricine regulates prostate cancer progression by inhibiting PI3K/AKT-dependent M2 polarization of macrophages.
Li M; Che N; Liu X; Xuan Y; Jin Y
Biochem Pharmacol; 2023 Nov; 217():115838. PubMed ID: 37778445
[TBL] [Abstract][Full Text] [Related]
17. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
18. Macrophage inhibitory cytokine-1 induced by a high-fat diet promotes prostate cancer progression by stimulating tumor-promoting cytokine production from tumor stromal cells.
Huang M; Narita S; Koizumi A; Nara T; Numakura K; Satoh S; Nanjo H; Habuchi T
Cancer Commun (Lond); 2021 May; 41(5):389-403. PubMed ID: 33773090
[TBL] [Abstract][Full Text] [Related]
19. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
